Healthcare · NSE: RUBICON
Rubicon Research Limited
₹1,564.00
+3.60% · close 28 Oct 2026
52-week range
₹600.45 – ₹1,860.60
From 52W high
-15.94%
Return 1Y
+152.99%
Volume · Avg 20D
1.27 L · 2.07 L
Returns & technicals
1W+7.97%
1M-6.70%
3M+1.85%
6M+63.13%
1Y+152.99%
| 50-day average | ₹1,673.78 below |
| 200-day average | ₹1,192.76 above |
| Volatility (1Y, annualised) | 43.76% |
| RSI (14) | 50.4 |
| MACD histogram (12, 26, 9) | 7.24 |
| Delivery · 20D avg | 45.69% · 52.44% |
| Turnover (last day) | ₹20 Cr |
Profile
| Symbol | RUBICON |
| ISIN | INE506V01022 |
| Sector | Healthcare |
| Listed on NSE | 16 Oct 2025 |
| Face value | ₹1 |
| Series | EQ |
Financials & shareholding
Quarterly results and the shareholding pattern for RUBICON aren't available right now.
Peers in Healthcare
| Stock | Price | Day | 1M | 1Y |
|---|---|---|---|---|
| PPLPHARMA Piramal Pharma Limited | ₹232.80 | +17.15% | +10.69% | +15.19% |
| SYNGENE Syngene International Limited | ₹410.85 | +12.19% | +8.49% | -37.51% |
| ACUTAAS Acutaas Chemicals Limited | ₹3,710.00 | -2.20% | +13.37% | +116.38% |
| DIVISLAB Divi's Laboratories Limited | ₹9,558.50 | +0.56% | -0.63% | +48.46% |
| ONESOURCE Onesource Specialty Pharma Limited | ₹1,577.60 | -0.77% | -1.56% | -14.00% |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137.00 | +4.43% | -8.46% | +3.25% |